<html><body><pre>[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2444 Introduced in House (IH)]

114th CONGRESS
  1st Session
                                H. R. 2444

  To authorize the Commissioner of Food and Drugs to award grants for 
         studying the process of continuous drug manufacturing.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 19, 2015

 Mr. Guthrie introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
  To authorize the Commissioner of Food and Drugs to award grants for 
         studying the process of continuous drug manufacturing.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. GRANTS FOR STUDYING THE PROCESS OF CONTINUOUS DRUG 
              MANUFACTURING.

    (a) In General.--The Commissioner of Food and Drugs may award 
grants to institutions of higher education and nonprofit organizations 
for the purpose of studying and recommending improvements to the 
process of continuous manufacturing of drugs and biological products 
and similar innovative monitoring and control techniques.
    (b) Definitions.--In this section:
            (1) The term ``drug'' has the meaning given to such term in 
        section 201 of the Federal Food, Drug, and Cosmetic Act (21 
        U.S.C. 321).
            (2) The term ``biological product'' has the meaning given 
        to such term in section 351(i) of the Public Health Service Act 
        (42 U.S.C. 262(i)).
            (3) The term ``institution of higher education'' has the 
        meaning given to such term in section 101 of the Higher 
        Education Act of 1965 (20 U.S.C. 1001).
    (c) Authorization of Appropriations.--There is authorized to be 
appropriated $5,000,000 for each of fiscal years 2016 through 2020 to 
carry out this section.
                                 &lt;all&gt;
</pre></body></html>
